When Brian Sullivan, MD was in college, his grandmother was diagnosed with colon cancer. Despite undergoing colonoscopy screenings every three years, her cancer was not identified early.

Diane Havlir is a pioneer in HIV/AIDS research treatment, whose work has helped to transform HIV from a death sentence to a manageable chronic disease.

Following in the footsteps of legendary Duke surgeon David Sabistan, current Chairman of Surgery Allan Kirk is one of the most respected transplant surgeons in the world.

Radiation oncologist Karen Winkfield has been honored throughout the country for her research and advocacy to improve access and health outcomes for minorities.

Why do perfectly good cancer treatments suddenly stop working? Researcher and lymphoma survivor Kris Wood is finding answers.

A more than 30-year commitment to understanding human metabolic regulation has helped Christopher Newgard discover new insights and potential new therapies for metabolic diseases such as diabetes, obesity, and cardiovascular disease.

Kafui Dzirasa’s work on neuro-engineering technologies is nothing short of revolutionary, which hold great promise for treating psychiatric illnesses.

Juan Battle founded Elias Santana Hospital for the Poor in Santo Domingo, and took the Dominican Republic out of the dark ages of eye care.

Robert Margolis is a pioneer in new models of team-based, coordinated health care, and has been on the front lines of health care reform for more than 40 years.

Researchers at the Duke Cancer Institute are teaming up with several other institutions to develop a fluorescent dye that is injected into cancerous tumors and lights up when viewed under a special camera. This allows surgeons to see if residual cancer remains after the tumor has been removed.